Aug 2026
Engineered extracellular vesicles targeting BACE1 reduces amyloid-beta plaque formation in a genetic mouse model of Alzheimer’s Disease
A proof-of-concept feasibility is established for EV-mediated delivery of Bace1-targeting siRNA to the brain and further development of engineered EVs as a therapeutic platform for neurodegenerative diseases is supported.
V. S. Kalluri, Sara P. Y. Che, Meagan R. Conner et al.
· bioRxiv · 0 citations